Showing results (121-130 of 282) with videos related to
Sort By:
Pageof 29
Expert Opinion on Drug Safety|October 11, 2016
Monitoring safety and use of old and new treatment options for type 2 diabetic patients: a two-year (2013-2016) analysisChristian Leporini, Rosanna Piro, Francesco Ursini, et al.Pharmacological Research|December 21, 2012
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 miceEmilio Russo, Eugenio Donato di Paola, Pietro Gareri, et al.Neurology and Therapy|October 2, 2025
Safety and Effectiveness of Direct Oral Anticoagulants in Combination with Antiseizure Medications: Protocol for a Systematic Review and Meta-analysisKai Michael Schubert, Johan Zelano, David J Seiffge, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 21, 2026
Early sedation-related adverse events with the cenobamate-clobazam combination in drug-resistant epilepsy: real-world preliminary observationsGiovanni Falcicchio, Valeria Delmonte, Teresa Francavilla, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 17, 2019
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behaviorAntonio Leo, Rita Citraro, Martina Tallarico, et al.Molecular Neurobiology|August 14, 2020
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of MetforminValentina Nesci, Emilio Russo, Biagio Arcidiacono, et al.Expert Opinion on Pharmacotherapy|November 8, 2018
Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsyAlessandra Morano, Luigi Iannone, Caterina Palleria, et al.Current Drug Safety|August 1, 2019
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case ReportStefano Dastoli, Luigi Francesco Iannone, Luigi Bennardo, et al.CNS & Neurological Disorders Drug Targets|November 9, 2016
The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy TreatmentAntonio Leo, Rita Citraro, Rosario Marra, et al.Current Stem Cell Research & Therapy|November 28, 2014
Targeting endothelial progenitor cells in cancer as a novel biomarker and anti-angiogenic therapyMichele Ammendola, Christian Leporini, Maria Luposella, et al.Pageof 29